In contrast, van der Burg et al. failed to show a significant correlation between PAI-1 levels and prognosis in 90 patients with ovarian cancer, although PAI-1 expression was significantly increased in adenocarcinomas compared to normal tissue or benign adenomas [13]. This evidence concerns the gene SERPINE1 and ovarian carcinoma.